Observational Study for the Evaluation of Immune-mediated Endocrinological Adverse Events in Patients With Hematological Malignancies and Subjected to Treatment With Immune-checkpoint Inhibitors
NCT06851702 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-02-28
Summary
Retrospective / prospective observational study of endocrinological adverse events in hematologic patients treated with immunological checkpoint inhibitors
Conditions
Sponsors & Collaborators
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-30
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Screening for Hematology Branch Protocols
NCT00001620 ·Status: ENROLLING_BY_INVITATION
-
Development of a Multi-biomarker Panel for Prognostic Stratification and Treatment Response Prediction in Acute Graft Versus Host Disease of the Gut
NCT07305090 ·Status: RECRUITING
-
Immunological Follow-up After Allogeneic Hematopoietic Stem Cell Transplantation
NCT03965429 ·Status: ACTIVE_NOT_RECRUITING
-
National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia
NCT07019766 ·Status: RECRUITING
-
National Marrow Donor Program Long-Term Donor Follow-Up
NCT01362179 ·Status: COMPLETED
-
Evaluation, Treatment, and Training for Patients With Blood Disorders
NCT00001397 ·Status: COMPLETED
-
Role of aGVHD Biomarkers on aGVHD Risks
NCT04284904 ·Status: COMPLETED
-
Immuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Stem Cell Transplant
NCT00231712 ·Status: UNKNOWN
-
The Use of Intensive Care in Critically Ill Cancer Haematological Patients: "TRIAL-OH"
NCT01172132 ·Status: COMPLETED
-
An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors
NCT05481502 ·Status: RECRUITING ·Phase: NA
-
Immunomonitoring After Hematopoietic Stem Cell Transplantation
NCT04635397 ·Status: ACTIVE_NOT_RECRUITING
-
Observational Study in Patients Who Underwent an Haploidentical Transplantation With T-repleted Bone Marrow
NCT02049424 ·Status: TERMINATED
-
Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood
NCT00143884 ·Status: TERMINATED ·Phase: PHASE2
-
Critical Illness After Hematopoietic Cell Transplantation
NCT07328724 ·Status: NOT_YET_RECRUITING
-
Observational Study Evaluating the Potential Impact of Procalcitonin Testing on Care of Stemcell Transplant Recipients
NCT02035189 ·Status: COMPLETED
-
A Randomized Controlled, Open, Single-center Clinical Study Evaluating the Efficacy and Safety of Umbilical Cord Blood Mononuclear Cells in Patients with Refractory Immune Effector Cell-related Hemocytopenia
NCT06729320 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202)
NCT01879072 ·Status: COMPLETED
-
Biomarkers Impact Evaluation on the Post-transplant Immune Response After Allografting of Hematopoietic Stem Cells
NCT04517656 ·Status: RECRUITING ·Phase: NA
-
Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
NCT04528355 ·Status: RECRUITING
-
Improving Blood Stem Cell Collection and Transplant Procedures
NCT01517035 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive Chemotherapy and Radiation Preceding a Bone Marrow Transplant
NCT00004994 ·Status: COMPLETED
-
The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies
NCT00001432 ·Status: COMPLETED
-
Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers
NCT01597219 ·Status: COMPLETED ·Phase: PHASE2
-
Intensive Induction Therapy Followed by High Dose Chemo and BM Transplant for Mantle Cell Lymphoma
NCT00586755 ·Status: COMPLETED ·Phase: PHASE2
-
IMMUNOPHENOTYPE ROLE IN THE EVALUATION OF CLINICAL RESPONSE
NCT02023671 ·Status: UNKNOWN